Regulation of Hepatic Insulin Extraction
NCT00811044 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2018-06-27
Summary
* This study is in the area of Type 2 diabetes and genetics
* Healthy Volunteers and those with mild type 2 diabetes may be eligible to participate
* This study is searching for genes that may affect the body's processing/digestion of glucose/sugar
Conditions
Sponsors & Collaborators
-
University of Chicago
collaborator OTHER -
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
Washington University School of Medicine
lead OTHER
Principal Investigators
-
Kenneth S Polonsky, MD · Washington University School of Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-10-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
More Related Trials
-
Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes
NCT05014204 ·Status: COMPLETED ·Phase: NA
-
The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients
NCT00791076 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
NCT00004419 ·Status: COMPLETED ·Phase: NA
-
Duodenal Exclusion for the Treatment of Type 2 Diabetes
NCT00534547 ·Status: WITHDRAWN ·Phase: NA
-
Incretin Action in Physiology and Diabetes
NCT02550548 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Pulsatile Insulin Secretion (A Study Investigating the Effects of Partial Pacreatectomy on Glucose Metabolism)
NCT00841867 ·Status: COMPLETED
-
Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus
NCT05985135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
NCT00609154 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients
NCT00596973 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
NCT04466566 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Incretin Effect in Cystic Fibrosis
NCT01975259 ·Status: COMPLETED
-
Studies of Insulin and Glucagon Action in the Liver
NCT07300982 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Arginine-stimulated Indication of Early Outcome After Islet Transplantation
NCT05540197 ·Status: ENROLLING_BY_INVITATION
-
Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
NCT06126419 ·Status: RECRUITING ·Phase: NA
-
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
NCT05098470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study
NCT03014323 ·Status: WITHDRAWN ·Phase: PHASE1
-
Human Versus Analogue Insulin in Patients After Pancreatectomy.
NCT04690309 ·Status: UNKNOWN ·Phase: PHASE4
-
Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion
NCT01176708 ·Status: UNKNOWN ·Phase: NA
-
The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia
NCT00639613 ·Status: COMPLETED
-
Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes
NCT03582956 ·Status: TERMINATED ·Phase: NA
-
Regulation of Insulin Secretion by the GLP-1 Receptor
NCT02844907 ·Status: TERMINATED ·Phase: PHASE4
-
Leptin to Treat Severe Insulin Resistance - Pilot Study
NCT00027456 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy
NCT02175459 ·Status: RECRUITING
-
The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Mellitus
NCT00568620 ·Status: COMPLETED ·Phase: NA
-
Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes
NCT01680133 ·Status: COMPLETED